Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | MEDI9253 |
Synonyms | |
Therapy Description |
MEDI9253 is a strain of the avian paramyxovirus Newcastle disease virus (NDV) engineered to encode human IL-12, which may promote anti-tumor immune response (PMID: 26303327). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
MEDI9253 | MEDI-9253|MEDI 9253 | MEDI9253 is a strain of the avian paramyxovirus Newcastle disease virus (NDV) engineered to encode human IL-12, which may promote anti-tumor immune response (PMID: 26303327). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|